Scapa (SCPA) was pushed into a first-half loss by medical technology group ConvaTec’s (CTEC) decision to exit a supply deal early, over which Scapa is pursuing $83m (£64m) in damages.
To continue reading, subscribe today
and enjoy unlimited access to the following:
- Tips of the Week
- Funds coverage
- Weekly features on big investment themes
- Trading ideas
- Comprehensive companies coverage
- Economic analysis
